{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:25:34Z","timestamp":1767705934259},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,9]]},"DOI":"10.7759\/cureus.40190","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T17:07:11Z","timestamp":1686330431000},"source":"Crossref","is-referenced-by-count":8,"title":["Concurrent Radiation and Targeted Therapy for Papillary Craniopharyngioma: A Case Report"],"prefix":"10.7759","author":[{"given":"Sophia N","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praneet C","family":"Kaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohan S","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunjay A","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-59602-4.00016-2","article-title":"Craniopharyngioma","volume":"124","author":"M\u00fcller HL","year":"2014","unstructured":"M\u00fcller HL. Craniopharyngioma. Handb Clin Neurol. 2014, 124:235-53. 10.1016\/B978-0-444-59602-4.00016-2","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21771","article-title":"Craniopharyngioma: a pathologic, clinical, and surgical review","volume":"34","author":"Fernandez-Miranda JC","year":"2012","unstructured":"Fernandez-Miranda JC, Gardner PA, Snyderman CH, et al.. Craniopharyngioma: a pathologic, clinical, and surgical review. Head Neck. 2012, 34:1036-44. 10.1002\/hed.21771","journal-title":"Head Neck"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-18","article-title":"Craniopharyngioma","volume":"2","author":"Garnett MR","year":"2007","unstructured":"Garnett MR, Puget S, Grill J, Sainte-Rose C. Craniopharyngioma. Orphanet J Rare Dis. 2007, 2:18. 10.1186\/1750-1172-2-18","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos142","article-title":"Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program","volume":"14","author":"Zacharia BE","year":"2012","unstructured":"Zacharia BE, Bruce SS, Goldstein H, Malone HR, Neugut AI, Bruce JN. Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neuro Oncol. 2012, 14:1070-8. 10.1093\/neuonc\/nos142","journal-title":"Neuro Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000504512","article-title":"The diagnosis and treatment of craniopharyngioma","volume":"110","author":"M\u00fcller HL","year":"2020","unstructured":"M\u00fcller HL. The diagnosis and treatment of craniopharyngioma. Neuroendocrinology. 2020, 110:753-66. 10.1159\/000504512","journal-title":"Neuroendocrinology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.11.5240","article-title":"Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence","volume":"83","author":"Bu\u0308low B","year":"1998","unstructured":"Bu\u0308low B, Attewell R, Hagmar L, Malmstro\u0308m P, Nordstro\u0308m C, Erfurth E. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. J Clin Endocrinol Metab. 1998, 83:3897-3904. 10.1210\/jcem.83.11.5240","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882381","article-title":"Neoadjuvant B-RAF and MEK inhibitor targeted therapy for adult papillary craniopharyngiomas: a new treatment paradigm","volume":"13","author":"Calvanese F","year":"2022","unstructured":"Calvanese F, Jacquesson T, Manet R, et al.. Neoadjuvant B-RAF and MEK inhibitor targeted therapy for adult papillary craniopharyngiomas: a new treatment paradigm. Front Endocrinol (Lausanne). 2022, 13:882381. 10.3389\/fendo.2022.882381","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref8","article-title":"Intensity-modulated fractionated stereotactic radiotherapy with reduced margin for high grade gliomas: dosimetric analysis of sparing optic nerve & chiasm","volume":"2","author":"Koh HK","year":"2013","unstructured":"Koh HK, Kim CY, Han JH, Kim YJ, Kim HJ, Kim JS, Kim IA. Intensity-modulated fractionated stereotactic radiotherapy with reduced margin for high grade gliomas: dosimetric analysis of sparing optic nerve & chiasm. J Radiosurg SBRT. 2013, 2:307-14.","journal-title":"J Radiosurg SBRT"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/153303460200100107","article-title":"Initial clinical results of stereotactic radiotherapy for the treatment of craniopharyngiomas","volume":"1","author":"Selch MT","year":"2002","unstructured":"Selch MT, DeSalles AA, Wade M, et al.. Initial clinical results of stereotactic radiotherapy for the treatment of craniopharyngiomas. Technol Cancer Res Treat. 2002, 1:51-9. 10.1177\/153303460200100107","journal-title":"Technol Cancer Res Treat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty KT","year":"2012","unstructured":"Flaherty KT, Infante JR, Daud A, et al.. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med. 2012, 367:1694-703. 10.1056\/NEJMoa1210093","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S119428","article-title":"BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy","volume":"9","author":"Chowdhary M","year":"2016","unstructured":"Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK. BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy. Onco Targets Ther. 2016, 9:7149-59. 10.2147\/OTT.S119428","journal-title":"Onco Targets Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31838","article-title":"Intracranial control with combination BRAF and MEK inhibitor therapy in patients with metastatic melanoma","volume":"14","author":"Hui C","year":"2022","unstructured":"Hui C, Wu YF, Liu K, et al.. Intracranial control with combination BRAF and MEK inhibitor therapy in patients with metastatic melanoma. Cureus. 2022, 14:e31838. 10.7759\/cureus.31838","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.586029","article-title":"Efficacy of BRAF inhibitors in combination with stereotactic radiosurgery for the treatment of melanoma brain metastases: a systematic review and meta-analysis","volume":"10","author":"Khan M","year":"2020","unstructured":"Khan M, Zheng T, Zhao Z, Arooj S, Liao G. Efficacy of BRAF inhibitors in combination with stereotactic radiosurgery for the treatment of melanoma brain metastases: a systematic review and meta-analysis. Front Oncol. 2020, 10:586029. 10.3389\/fonc.2020.586029","journal-title":"Front Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26149","article-title":"The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study","volume":"9","author":"Tietze JK","year":"2018","unstructured":"Tietze JK, Forschner A, Loquai C, et al.. The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study. Oncotarget. 2018, 9:34336-46. 10.18632\/oncotarget.26149","journal-title":"Oncotarget"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2020.7624","article-title":"Successful use of BRAF\/MEK inhibitors as a neoadjuvant approach in the definitive treatment of papillary craniopharyngioma","volume":"18","author":"Khaddour K","year":"2020","unstructured":"Khaddour K, Chicoine MR, Huang J, Dahiya S, Ansstas G. Successful use of BRAF\/MEK inhibitors as a neoadjuvant approach in the definitive treatment of papillary craniopharyngioma. J Natl Compr Canc Netw. 2020, 18:1590-5. 10.6004\/jnccn.2020.7624","journal-title":"J Natl Compr Canc Netw"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.01.038","article-title":"Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: consensus guidelines from the Eastern Cooperative Oncology Group (ECOG)","volume":"95","author":"Anker CJ","year":"2016","unstructured":"Anker CJ, Grossmann KF, Atkins MB, Suneja G, Tarhini AA, Kirkwood JM. Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: consensus guidelines from the Eastern Cooperative Oncology Group (ECOG). Int J Radiat Oncol Biol Phys. 2016, 95:632-46. 10.1016\/j.ijrobp.2016.01.038","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/148566-concurrent-radiation-and-targeted-therapy-for-papillary-craniopharyngioma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:05Z","timestamp":1707508865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/148566-concurrent-radiation-and-targeted-therapy-for-papillary-craniopharyngioma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.40190","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,9]]}}}